Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03743610 · ClinicalTrials.gov registry record · NA
Physiological Adaptations to Simulated Intermittent Altitude on Human Health and Performance
A NA study of Altitude Hypoxia, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
- 1
- Study location
NCT03743610: Completed NA study of Altitude Hypoxia, sponsored by Mayo Clinic.
NCT03743610 is a NA study of Altitude Hypoxia that has completed, run by Mayo Clinic. The registered enrollment target is 71 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03743610, a NA study of Altitude Hypoxia, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators expect to find that different intensity and altitude exposure levels will show what kind of intermittent exposure protocol is more beneficial to athletes and healthy individuals that experience acute exposure to altitude during exercise. This may furthermore be related to acute altitude exposure for recreational exercise use as well.
Conditions Studied
Interventions
- OTHER Simulated altitude
- OTHER Placebo simulated altitude
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2023-10-25 |
| Phase | NA |
What the finished NCT03743610 record still lists
NCT03743610 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Altitude Hypoxia appearing as the primary indexed condition, and to 2 interventions - of which Simulated altitude is the first listed.
NCT03743610 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT03743610 about?
NCT03743610 is a clinical study titled "Physiological Adaptations to Simulated Intermittent Altitude on Human Health and Performance". The investigators expect to find that different intensity and altitude exposure levels will show what kind of intermittent exposure protocol is more beneficial to athletes and healthy individuals that experience acute exposure to altitude during exercise. This may furthermore be related to acute alt...
What is the current status of trial NCT03743610?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2019-01-01. Estimated completion is 2023-10-25.
What conditions does trial NCT03743610 study?
This clinical trial studies the following conditions: Altitude Hypoxia.
What interventions are being tested in trial NCT03743610?
The interventions under investigation include: Simulated altitude (OTHER), Placebo simulated altitude (OTHER).
Who is sponsoring clinical trial NCT03743610?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03743610 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Altitude Hypoxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03743610's enrollment target sits among peer trials
71 1102nd of 2000 higher than 898 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI